NEXGEL, INC. Logo

NEXGEL, INC.

Manufactures skin-friendly hydrogel patches for healthcare, cosmetic, and wellness uses.

NXGL | US

Overview

Corporate Details

ISIN(s):
US65344E1073
LEI:
Country:
United States of America
Address:
2150 CABOT BLVD WEST,, 19047 LANGHORNE

Description

NEXGEL, Inc. is a manufacturer specializing in high water content, electron-beam cross-linked aqueous polymer hydrogels. The company's core business revolves around its proprietary hydrogel platform technology, which produces skin-friendly patches for a variety of applications. Operating from an FDA registered and ISO certified facility, NEXGEL develops and manufactures these hydrogels both with and without active ingredients. The products are utilized across several sectors, including healthcare for wound care and transdermal drug delivery systems; cosmetics for skin hydration and beauty treatments; and consumer wellness for applications like foot care and pain relief. The company offers a range of hydrogel formulations, including high-hydration, versatile ingredient-carrying, and biodegradable options, emphasizing gentle, low-irritation solutions for sensitive skin.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEXGEL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXGEL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXGEL, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CKD Bio Corp. Logo
Develops APIs, intermediates, and probiotics using fermentation and synthesis.
South Korea
063160
Clearmind Medicine Inc. Logo
Clinical-stage psychedelic pharma firm developing treatments for Alcohol Use Disorder.
United States of America
CMND
Clearside Biomedical, Inc. Logo
Biopharmaceutical firm with an FDA-approved microinjector for back-of-the-eye delivery.
United States of America
CLSD
Clene Inc. Logo
A clinical-stage biopharma developing nanotherapeutics for neurodegenerative diseases.
United States of America
CLNN
CMG Pharmaceutical Co., Ltd. Logo
A pharmaceutical firm specializing in Oral Thin Film drug delivery technology.
South Korea
058820
CNS Pharmaceuticals, Inc. Logo
Develops anti-cancer drug candidates for cancers of the brain and nervous system.
United States of America
CNSP
Cocrystal Pharma, Inc. Logo
Clinical-stage biotech developing antiviral drugs for serious and chronic viral diseases.
United States of America
COCP
Co-Diagnostics, Inc. Logo
A molecular diagnostics company that develops and markets advanced PCR technologies.
United States of America
CODX
co.don AG Logo
Develops autologous cell therapies for regenerative treatment of cartilage defects.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Biopharmaceutical company developing cell therapy platforms for cancer and other diseases.
United States of America
COEP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.